High-risk biochemical recurrence in prostate cancer: identification and early intervention strategies

Key Points

• Improved patient outcomes depend on the use of standardized protocols and androgen receptor pathway inhibitors, along with multidisciplinary strategies.
• Advanced diagnostics play a critical role in identifying high-risk biochemical recurrence, enabling timely interventions.
• Narrative review highlights the necessity of refining predictive models to enhance therapeutic efficacy and resource allocation.
• Calls for further research to optimize strategies for early intervention in prostate cancer, indicating the potential to improve care.